Contact
Please use this form to send email to PR contact of this press release:
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US
TO:
Please use this form to send email to PR contact of this press release:
FDA approves biosimilar Pyzchiva® (ustekinumab-ttwe), to be commercialized by Sandoz in US
TO: